Global Kidney Function Market Size, Share, Forecast Report, 2020-2027

The global kidney function test market is expected to reach an approximate CAGR of 5.7% during the forecast period. Kidney function tests are carried out to evaluate the functioning of kidneys.

The kidney function test market is expected to witness growth owing to the rising prevalence of chronic kidney diseases. According to the Centers for Disease Control and Prevention (2017), 30 million people in the U.S. suffer from Chronic Kidney Disease (CKD). Other key factors such as an increase in alcohol consumption, change to sedentary lifestyle, growing prevalence of diabetes, rising obesity, and increasing prevalence of cardiovascular diseases are contributing towards the growth of the market. Diabetes is associated with kidney disorders because diabetes damage the blood vessels of kidneys which leads to improper functioning of kidneys. Such conditions contribute to risk for kidney disorders. According to the Centers for Disease Control and Prevention 2017, 44% of the diabetic patients suffered from End-Stage Renal Disease (ESRD) in the U.S. The prevalence of diabetes increases the potential patients for kidney function test, providing favorable backgrounds for the market to grow. Also, other factors such as growing geriatric population and technological advancements drive the growth of the market.

However, factors such as high cost of diagnostic procedures, infections, and huge initial investments are expected to restrict the market growth during the forecast period.

Key players

Some of the key players in the global kidney function test market are Urit Medical, Sysmex Corporation, Siemens Healthcare GmbH (Germany), F. Hoffmann-La Roche Ltd., Randox Laboratories, Opti Medical, Nova Biomedical, Beckman Coulter, ARKRAY, Inc., Acon Laboratories, Abbott, Cook Medical, 77 Elektronika, Medical Care (Germany), Baxter (U.S.), Boston Scientific (U.S.), and others.

Segmentation

The global kidney function test market is segmented on the basis of tests, product, and end-user. The kidney function test market, by tests, is categorized into blood tests, imaging tests, urine tests balloons, and kidney biopsy. The blood tests category includes serum creatinine, Glomerular Filtration Rate (GFR), and Blood Urea Nitrogen (BUN). The imaging tests segment includes ultrasound and CT scan. The urine tests category includes urinalysis, urine protein, microalbuminuria, and creatinine clearance. The product segment is segmented into dipsticks, disposables, and reagents. On the basis of end-user, the market is segmented into hospitals and clinics, diagnostic laboratories, ambulatory surgical centers, academic research laboratories, and others.

On the basis of region, the global kidney function test market is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa. The Americas is sub-segmented into North America and South America. The North American region is further segmented into the U.S. and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the U.K., Spain, and the rest of Western Europe. The Asia Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa.